15 Jul 2015 05:18
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
BTG Share News (BTG)
BTG Share
Price
BTG Share
News
BTG Share
Chat
BTG Share
Trades
BTG
Live RNS
BTG Share
Charts
BTG Broker
Ratings
BTG Directors
Deals
BTG Financial
Diary
BTG
Fundamentals
BTG Short
Positions
BTG
Media
BTG Information
- There is currently no data for BTG
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Wednesday broker round-up
Wed, 26th Oct 2016 17:40
(ShareCast News) - FirstGroup: Goldman Sachs keeps at buy with a target price of 168p.Esure: Berenberg stays at sell, 238p target.Anglo American: Deutsche Bank reiterates hold with a 965p target.Intertek: UBS reiterates buy with a 4100p target.Sainsbury: Goldman Sachs reiterates sell with a 195p target.Whitbread: Societe Generale downgrades to hold with a target price of 4100p.BTG: Deutsche Bank keeps at buy with a target price of 865p.Tesco: Goldman Sachs stays at sell with a 145p target.Bodycote: UBS reiterates sell with a 705p target.Diageo: JP Morgan stays at overweight with a 2500p target.St James Place: JP Morgan reiterates overweight with a 1096p target.
More News
14 Jul 2015 14:59
14 Jul 2015 05:18
13 Jul 2015 15:07
13 Jul 2015 05:17
10 Jul 2015 16:11
10 Jul 2015 05:17
9 Jul 2015 15:21
9 Jul 2015 05:23
8 Jul 2015 15:20
29 Jun 2015 14:51
Investec affirms 'buy' rating for BTG, confident about varicose vein treatment
Investec reiterated a 'buy' rating and price target of 647p for pharmaceuticals firm BTG after reappraising its key product Varithena. The bank said investors overreacted to concerns over BTG's earning profile, in particular the varicose vein treatment Varithena. "After interviewing physicians and
Read more